Vesna D Garovic1, Wendy M White2, Lisa Vaughan3, Mie Saiki4, Santosh Parashuram4, Oscar Garcia-Valencia4, Tracey L Weissgerber4, Natasa Milic5, Amy Weaver3, Michelle M Mielke6. 1. Division of Nephrology and Hypertension, Mayo Clinic College of Medicine, Rochester, Minnesota; Department of Obstetrics and Gynecology, Mayo Clinic College of Medicine, Rochester, Minnesota. Electronic address: garovic.vesna@mayo.edu. 2. Department of Obstetrics and Gynecology, Mayo Clinic College of Medicine, Rochester, Minnesota. 3. Division of Biomedical Statistics and Informatics, Mayo Clinic College of Medicine, Rochester, Minnesota. 4. Division of Nephrology and Hypertension, Mayo Clinic College of Medicine, Rochester, Minnesota. 5. Division of Nephrology and Hypertension, Mayo Clinic College of Medicine, Rochester, Minnesota; Department of Medical Statistics & Informatics, Medical Faculty, University of Belgrade, Belgrade, Serbia. 6. Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, Minnesota; Department of Neurology, Mayo Clinic College of Medicine, Rochester, Minnesota.
Abstract
BACKGROUND: Hypertensive disorders of pregnancy (HDP) are associated with increased risks for cardiovascular disease later in life. The HDP incidence is commonly assessed using diagnostic codes, which are not reliable; and typically are expressed per-pregnancy, which may underestimate the number of women with an HDP history after their reproductive years. OBJECTIVES: This study sought to determine the incidence of HDP expressed as both per-pregnancy and per-woman, and to establish their associations with future chronic conditions and multimorbidity, a measure of accelerated aging, in a population-based cohort study. METHODS: Using the Rochester Epidemiology Project medical record-linkage system, the authors identified residents of Olmsted County, Minnesota, who delivered between 1976 and 1982. The authors classified pregnancies into normotensive, gestational hypertension, pre-eclampsia, eclampsia, pre-eclampsia superimposed on chronic hypertension, and chronic hypertension using a validated electronic algorithm, and calculated the incidence of HDP both per-pregnancy and per-woman. The risk of chronic conditions between women with versus those without a history of HDP (age and parity 1:2 matched) was quantified using the hazard ratio and corresponding 95% confidence interval estimated from a Cox model. RESULTS: Among 9,862 pregnancies, we identified 719 (7.3%) with HDP and 324 (3.3%) with pre-eclampsia. The incidence of HDP and pre-eclampsia doubled when assessed on a per-woman basis: 15.3% (281 of 1,839) and 7.5% (138 of 1,839), respectively. Women with a history of HDP were at increased risk for subsequent diagnoses of stroke (hazard ratio [HR]: 2.27; 95% confidence interval [CI]: 1.37 to 3.76), coronary artery disease (HR: 1.89; 95% CI: 1.26 to 2.82), cardiac arrhythmias (HR: 1.62; 95% CI: 1.28 to 2.05), chronic kidney disease (HR: 2.41; 95% CI: 1.54 to 3.78), and multimorbidity (HR: 1.25; 95% CI: 1.15 to 1.35). CONCLUSIONS: The HDP population-based incidence expressed per-pregnancy underestimates the number of women affected by this condition during their reproductive years. A history of HDP confers significant increase in risks for future chronic conditions and multimorbidity.
BACKGROUND:Hypertensive disorders of pregnancy (HDP) are associated with increased risks for cardiovascular disease later in life. The HDP incidence is commonly assessed using diagnostic codes, which are not reliable; and typically are expressed per-pregnancy, which may underestimate the number of women with an HDP history after their reproductive years. OBJECTIVES: This study sought to determine the incidence of HDP expressed as both per-pregnancy and per-woman, and to establish their associations with future chronic conditions and multimorbidity, a measure of accelerated aging, in a population-based cohort study. METHODS: Using the Rochester Epidemiology Project medical record-linkage system, the authors identified residents of Olmsted County, Minnesota, who delivered between 1976 and 1982. The authors classified pregnancies into normotensive, gestational hypertension, pre-eclampsia, eclampsia, pre-eclampsia superimposed on chronic hypertension, and chronic hypertension using a validated electronic algorithm, and calculated the incidence of HDP both per-pregnancy and per-woman. The risk of chronic conditions between women with versus those without a history of HDP (age and parity 1:2 matched) was quantified using the hazard ratio and corresponding 95% confidence interval estimated from a Cox model. RESULTS: Among 9,862 pregnancies, we identified 719 (7.3%) with HDP and 324 (3.3%) with pre-eclampsia. The incidence of HDP and pre-eclampsia doubled when assessed on a per-woman basis: 15.3% (281 of 1,839) and 7.5% (138 of 1,839), respectively. Women with a history of HDP were at increased risk for subsequent diagnoses of stroke (hazard ratio [HR]: 2.27; 95% confidence interval [CI]: 1.37 to 3.76), coronary artery disease (HR: 1.89; 95% CI: 1.26 to 2.82), cardiac arrhythmias (HR: 1.62; 95% CI: 1.28 to 2.05), chronic kidney disease (HR: 2.41; 95% CI: 1.54 to 3.78), and multimorbidity (HR: 1.25; 95% CI: 1.15 to 1.35). CONCLUSIONS: The HDP population-based incidence expressed per-pregnancy underestimates the number of women affected by this condition during their reproductive years. A history of HDP confers significant increase in risks for future chronic conditions and multimorbidity.
Authors: Kari Klungsøyr; Quaker E Harmon; Linn B Skard; Ingeborg Simonsen; Elise T Austvoll; Elin R Alsaker; Anne Starling; Lill Trogstad; Per Magnus; Stephanie M Engel Journal: Paediatr Perinat Epidemiol Date: 2014-07-18 Impact factor: 3.980
Authors: Kirsten Bibbins-Domingo; David C Grossman; Susan J Curry; Michael J Barry; Karina W Davidson; Chyke A Doubeni; John W Epling; Alex R Kemper; Alex H Krist; Ann E Kurth; C Seth Landefeld; Carol M Mangione; William R Phillips; Maureen G Phipps; Michael Silverstein; Melissa A Simon; Chien-Wen Tseng Journal: JAMA Date: 2017-04-25 Impact factor: 56.272
Authors: Sonja Suvakov; Hajrunisa Cubro; Wendy M White; Yvonne S Butler Tobah; Tracey L Weissgerber; Kyra L Jordan; Xiang Y Zhu; John R Woollard; Fouad T Chebib; Natasa M Milic; Joseph P Grande; Ming Xu; Tamara Tchkonia; James L Kirkland; Lilach O Lerman; Vesna D Garovic Journal: Biol Sex Differ Date: 2019-09-14 Impact factor: 5.027
Authors: Ki Park; C Noel Bairey Merz; Natalie A Bello; Melinda Davis; Claire Duvernoy; Islam Y Elgendy; Keith C Ferdinand; Afshan Hameed; Dipti Itchhaporia; Margo B Minissian; Harmony Reynolds; Puja Mehta; Andrea M Russo; Rashmee U Shah; Annabelle Santos Volgman; Janet Wei; Nanette K Wenger; Carl J Pepine; Kathryn J Lindley Journal: J Am Coll Cardiol Date: 2021-04-13 Impact factor: 24.094
Authors: Olayemi K Ijomone; Itohan R Osahon; Comfort O A Okoh; Grace T Akingbade; Omamuyovwi M Ijomone Journal: Metab Brain Dis Date: 2021-03-11 Impact factor: 3.584
Authors: Ian K Everitt; Priya M Freaney; Michael C Wang; William A Grobman; Matthew J O'Brien; Lindsay R Pool; Sadiya S Khan Journal: Circ Cardiovasc Qual Outcomes Date: 2022-01-18